C07F 9/74
Aromatic compounds
C07F9/74 (Aromatic compounds) appears on 56 US grants and 32 published applications in this corpus.
Search patents in C07F- Granted patents
- 56
- Published applications
- 32
- Assignees
- 38
- Inventors
- 114
- Latest grant
- 21 Apr 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1976 | 1 | 0 |
| 1977 | 0 | 0 |
| 1978 | 0 | 0 |
| 1979 | 1 | 0 |
| 1980 | 0 | 0 |
| 1981 | 2 | 0 |
| 1982 | 0 | 0 |
| 1983 | 3 | 0 |
| 1984 | 2 | 0 |
| 1985 | 3 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 1 | 0 |
| 1989 | 2 | 0 |
| 1990 | 3 | 0 |
| 1991 | 3 | 0 |
| 1992 | 3 | 0 |
| 1993 | 0 | 0 |
| 1994 | 0 | 0 |
| 1995 | 1 | 0 |
| 1996 | 0 | 0 |
| 1997 | 2 | 0 |
| 1998 | 2 | 0 |
| 1999 | 1 | 0 |
| 2000 | 1 | 0 |
| 2001 | 1 | 0 |
| 2002 | 1 | 0 |
| 2003 | 0 | 2 |
| 2004 | 2 | 1 |
| 2005 | 0 | 2 |
| 2006 | 3 | 2 |
| 2007 | 0 | 3 |
| 2008 | 1 | 2 |
| 2009 | 3 | 1 |
| 2010 | 1 | 3 |
| 2011 | 1 | 1 |
| 2012 | 2 | 0 |
| 2013 | 0 | 1 |
| 2014 | 1 | 2 |
| 2015 | 0 | 0 |
| 2016 | 2 | 3 |
| 2017 | 2 | 1 |
| 2018 | 1 | 0 |
| 2019 | 0 | 1 |
| 2020 | 1 | 0 |
| 2021 | 0 | 1 |
| 2022 | 0 | 1 |
| 2023 | 1 | 0 |
| 2024 | 0 | 4 |
| 2025 | 1 | 1 |
| 2026 | 1 | 0 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Organic light emitting device21 Apr 2026US 12,610,736 B2LG Chem.Ltd.
- Conjugates and their use as imaging agents13 May 2025US 12,296,030 B2Centenary Institute of Cancer Medicine and Cell Biology
- Anti-cancer agent comprising a tumour homing peptide having arsenic bonded to cysteine residues21 Nov 2023US 11,819,489 B2University of Wollongong
- Selective targeting of procoagulant platelets10 Nov 2020US 10,828,275 B2NewSouth Innovations Pty Limited
- Triarylphosphine or triarylarsine compound, alpha-olefin polymerization catalyst using the compound, ternary copolymer, and production process of alpha-olefin-((meth)acrylic acid)-based copolymer13 Feb 2018US 9,890,231 B2Japan Polyethylene Corporation
- Conjugates and their use as imaging agents23 Oct 2025US 2025/0325716 A1Centenary Institute of Cancer Medicine and Cell Biology
- Halogenated phenylarsine oxide compound and application thereof28 Nov 2024US 2024/0391942 A1Nuo-Beta Pharmaceutical Technology (Shanghai) Co.,Ltd.
- Applications of p14k inhibitor in intracellular protein misfolding-related diseases and lysosomal storage diseases8 Aug 2024US 2024/0261250 A1Nuo-Beta Pharmaceutical Technology (Shanghai) Co.,Ltd.
- Deuterated oxophenylarsine compound and use thereof15 Feb 2024US 2024/0050395 A1Nuo-Beta Pharmaceutical Technology (Shanghai) Co.,Ltd.
- Conjugates and their use as imaging agents11 Jan 2024US 2024/0009330 A1Centenary Institute of Cancer Medicine and Cell Biology
Most cited
By later US patents
- Synthetic molecules that specifically react with target sequences73US 6,008,378 AThe Regents of the University of California · 1999
- Synthetic molecules that specifically react with target sequences57US 6,451,569 B1The Regents of the University of California · 2002
- Onium salts and the use thereof as photoinitiators28US 5,141,969 AEastman Kodak Company · 1992
- Phosphine and phosphonium compounds and catalysts21US 4,522,932 AExxon Research & Engineering Co. · 1985
- Nickel ylides15US 4,293,502 AGulf Research & Development Company · 1981